BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8693717)

  • 1. [Erythropoietin in hematology and oncology. I. Chronic anemia in malignant disease and the pharmacology of erythropoietin].
    Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 1996 Apr; 42(4):285-9. PubMed ID: 8693717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin treatment of anemic cancer patients.
    Henry DH
    Cancer Pract; 1996; 4(4):180-4. PubMed ID: 8900758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythropoietin in oncology. II. Evaluation of the effectiveness of erythropoietin in hematologic and oncologic diseases].
    Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 1996 May; 42(5):351-8. PubMed ID: 8768296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma].
    Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
    Vnitr Lek; 1995 Nov; 41(11):767-72. PubMed ID: 8553596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin therapy in cancer patients.
    Doweiko JP; Goldberg MA
    Oncology (Williston Park); 1991 Aug; 5(8):31-7; discussion 38, 43-4. PubMed ID: 1834151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythropoietin in the treatment of anemias].
    Spicka I; Klener P; Lachmanová J; Háber J
    Vnitr Lek; 1996 Mar; 42(3):197-9. PubMed ID: 8686210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic use of recombinant human erythropoietin in clinical practice].
    Scudla V
    Vnitr Lek; 1995 Mar; 41(3):210-4. PubMed ID: 7762184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of anemia in patients with chronic renal insufficiency with recombinant human erythropoietin].
    Djukanović Lj; Lezaić V
    Srp Arh Celok Lek; 1996; 124(3-4):93-7. PubMed ID: 9102827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
    Monnerat C; Leyvraz S
    Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recombinant erythropoietin--a fundamental change in the treatment of anemia?].
    Sasinka M; Podracká L; Roland R
    Cesk Pediatr; 1992 Apr; 47(4):220-5. PubMed ID: 1628358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human recombinant erythropoietin: progress in clinical development.
    Kubiak W; Karwacki M; Mazur I
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():39-50. PubMed ID: 8192531
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant erythropoietin for anemia in inflammatory bowel disease.
    Fischer T
    N Engl J Med; 1996 Sep; 335(10):751-2. PubMed ID: 8786771
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic role of recombinant erythropoietin in anemic patients with intact endogenous production of erythropoietin.
    Erslev AJ
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):14-8. PubMed ID: 1615334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of anemia in chronically dialyzed patients].
    Moynot A
    Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum erythropoietin concentration in women with uterine or ovarian tumors].
    Chudek J; Wiecek A; Kokot F; Grochal A; Switała J; Kanwiszer J
    Przegl Lek; 1998; 55(2):47-50. PubMed ID: 9695642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and therapy of anemia in chronic diseases].
    Scudla V; Adam Z; Scudlová M
    Vnitr Lek; 2001 Jun; 47(6):400-6. PubMed ID: 11494888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia in the critically ill.
    Shander A
    Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blood in systemic disorders.
    Spivak JL
    Lancet; 2000 May; 355(9216):1707-12. PubMed ID: 10905258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KHA-CARI guideline: biochemical and haematological targets: haemoglobin concentrations in patients using erythropoietin-stimulating agents.
    McMahon LP; MacGinley R;
    Nephrology (Carlton); 2012 Jan; 17(1):17-9. PubMed ID: 22044720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.